Statement supporting HRT use for menopausal symptoms issued

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.475, 2005-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statement supporting HRT use for menopausal symptoms issued

Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Norethisterone Acetate/Ethinylestradiol (FemHRT ® ) for Women with Menopausal Symptoms

By Coyle D. Cranney A. Tugwell P.

PharmacoEconomics, Vol. 21, Iss. 9, 2003-01 ,pp. : 661-669

Adis International

Access to resources Recommend Favorite

The US FDA has issued a statement on the use of conjugated estrogens/medroxyprogesterone

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

A consensus statement on the use of IV immunoglobulins in patients with autoimmune mucocutaneous blister diseases has been issued

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 430, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A consensus statement on the use of biological agents to treat rheumatic diseases has been issued

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 467, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite